Keywords
- Systemic Lupus Erythematosus
- Systemic Lupus Erythematosus Patient
- Human Systemic Lupus Erythematosus
- Temic Lupus Erythematosus
- Defective Clearance
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Amoura, Z., Piette, J.C., Chabre, H., Cacoub, P., Papo, T., Wechsler, B., Bach, J.F., and Koutouzov, S. (1997). Circulating plasma levels of nucleosomes in patients with systemic lupus erythematosus: Correlation with serum antinucleosome antibody titers and absence of clear association with disease activity. Arthritis Rheum., 40, 2217–2225.
Bachmaier, K., Krawczyk, C., Kozieradzki, I., Kong, Y.Y., Sasaki, T., Oliveira-dos-Santos, A., Mariathasan, S., Bouchard, D., Wakeham, A., Itie, A., Le, J., Ohashi, P.S., Sarosi, I., Nishina, H., Lipkowitz, S., and Penninger, J.M. (2000). Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature, 403, 211–216.
Balomenos, D., Martin-Caballero, J., Garcia, M.I., Prieto, I., Flores, J.M., Serrano, M., and Martinez, A.C. (2000). The cell cycle inhibitor p21 controls T-cell proliferation and sex-linked lupus development. Nat. Med., 6, 171–176.
Bickerstaff, M.C., Botto, M., Hutchinson, W.L., Herbert, J., Tennent, G.A., Bybee, A., Mitchell, D.A., Cook, H.T., Butler, P.J., Walport, M.J., and Pepys, M.B. (1999). Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat. Med., 5, 694–697.
Boes, M., Schmidt, T., Linkemann, K., Beaudette, B.C., Marshak-Rothstein, A., and Chen, J. (2000). Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. Proc. Natl. Acad. Sci. USA, 97, 1184–1189.
Botto, M., Dell’Agnola, C., Bygrave, A.E., Thompson, E.M., Cook, H.T., Petry, F., Loos, M., Pandolfi, P.P., and Walport, M.J. (1998). Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet., 19, 56–59.
Brunkow, M.E., Jeffery, E.W., Hjerrild, K.A., Paeper, B., Clark, L.B., Yasayko, S.A., Wilkinson, J.E., Galas, D., Ziegler, S.F., and Ramsdell, F. (2001). Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet., 27, 68–73.
Casciola-Rosen, L.A., Anhalt, G., and Rosen, A. (1994). Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med., 179, 1317–1330.
Chiang, Y.J., Kole, H.K., Brown, K., Naramura, M., Fukuhara, S., Hu, R.J., Jang, I.K., Gutkind, J.S., Shevach, E., and Gu, H. (2000). Cbl-b regulates the CD28 dependence of T-cell activation. Nature, 403, 216–220.
Chitrabamrung, S., Rubin, R.L. and Tan, E.M. (1981). Serum deoxyribonuclease I and clinical activity in systemic lupus erythematosus. Rheumatol. Int., 1, 55–60.
Chui, D., Sellakumar, G., Green, R., Sutton-Smith, M., McQuistan, T., Marek, K., Morris, H., Dell, A., and Marth, J. (2001). Genetic remodeling of protein glycosylation in vivo induces autoimmune disease. Proc. Natl. Acad. Sci. USA, 98, 1142–1147.
Davidson, A. and Diamond, B. (2001). Autoimmune diseases. N. Engl. J. Med., 345, 340–350.
Davis, J.C., Jr., Manzi, S., Yarboro, C., Rairie, J., McInnes, I., Averthelyi, D., Sinicropi, D., Hale, V.G., Balow, J., Austin, H., Boumpas, D.T., and Klippel, J.H. (1999). Recombinant human Dnase I (rhDNase) in patients with lupus nephritis. Lupus, 8, 68–76.
DeGiorgio, L.A., Konstantinov, K.N., Lee, S.C., Hardin, J.A., Volpe, B.T., and Diamond, B. (2001). A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat. Med., 7, 1189–1193.
Demetriou, M., Granovsky, M., Quaggin, S., and Dennis, J.W. (2001). Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature, 409, 733–739.
Dorfman, J.R., Stefanova, I., Yasutomo, K., and Germain, R.N. (2000). CD4+ T cell survival is not directly linked to self-MHC-induced TCR signaling. Nat. Immunol., 1, 329–335.
Fagarasan, S. and Honjo, T. (2000). T-Independent immune response: New aspects of B cell biology. Science, 290, 89–92.
Filaci, G., Bacilieri, S., Fravega, M., Monetti, M., Contini, P., Ghio, M., Setti, M., Puppo, F., and Indiveri, F. (2001). Impairment of CD8+ T suppressor cell function in patients with active systemic lupus erythematosus. J. Immunol., 166, 6452–6457.
Germain, R.N. (2001). The T cell receptor for antigen: Signaling and ligand discrimination. J. Biol. Chem., 276, 35223–35226.
Hanayama, R., Tanaka, M., Miyasaka, K., Aozasa, K., Koike, M., Uchiyma, Y., and Nagata, S. (2004). Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science, 304, 1147–1150.
Kaliyaperumal, A., Michaels, M.A., and Datta, S.K. (1999). Antigen-specific therapy of murine lupus nephritis using nucleosomal peptides: Tolerance spreading impairs pathogenic function of autoimmune T and B cells. J. Immunol., 162, 5775–5783.
Kirschfink, M., Petry, F., Khirwadkar, K., Wigand, R., Kaltwasser, J.P., and Loos, M. (1993). Complete functional C1q deficiency associated with systemic lupus erythematosus (SLE). Clin. Exp. Immunol., 94, 267–272.
Lachmann, P.J. (1996). The in vivo destruction of antigen-A tool for probing and modulating an autoimmune response. Clin. Exp. Immunol., 106, 187–189.
Lanzavecchia, A., Lezzi, G., and Viola, A. (1999). From TCR engagement to T cell activation: A kinetic view of T cell behavior. Cell, 96, 1–4.
Le, L.Q., Kabarowski, J.H., Weng, Z., Satterthwaite, A.B., Harvill, E.T., Jensen, E.R., Miller, J.F., and Witte, O.N. (2001). Mice lacking the orphan G protein-coupled receptor G2A develop a lateonset autoimmune syndrome. Immunity, 14, 561–571.
Leadbetter, E.A., Rifkin, I.R., Hohlbaum, A.M., Beaudette, B.C., Shlomchik, M.J., and Marshak-Rothstein, A. (2002). Chromatin-IgG complexes activate B cells by dual engagement of IgM and toll-like receptors. Nature, 416, 603–607.
Leadbetter, E.A., Rifkin, I.R., and Marshak-Rothstein, A. (2003). Toll-like receptors and activation of autoreactive B cells. Curr. Dir. Autoimmun., 6, 105–122.
Liossis, S.N., Ding, X.Z., Dennis, G.J., and Tsokos, G.C. (1998). Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain. J. Clin. Invest., 101, 1448–1457.
Majeti, R., Xu, Z., Parslow, T.G., Olson, J.L., Daikh, D.I., Killeen, N., and Weiss, A. (2000). An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity. Cell, 103, 1059–1070.
Mevorach, D., Mascarenhas, J.O., Gershov, D., and Elkon, K.B. (1998a). Complement-dependent clearance of apoptotic cells by human macrophages. J. Exp. Med., 188, 2313–2320.
Mevorach, D., Zhou, J.L., Song, X., and Elkon, K.B. (1998b). Systemic exposure to irradiated apoptotic cells induces autoantibody production. J. Exp. Med., 188, 387–392.
Napirei, M., Karsunky, H., Zevnik, B., Stephan, H., Mannherz, H.G., and Moroy, T. (2000). Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat. Genet., 25, 177–181.
Nishimura, H., Nose, M., Hiai, H., Minato, N., and Honjo, T. (1999). Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity, 11, 141–151.
O’Keefe, T.L., Williams, G.T., Davies, S.L., and Neuberger, M.S. (1996). Hyperresponsive B cells in CD22-deficient mice. Science, 274, 798–801.
Poeck, H., Wagner, M., Battiany, J., Rothenfusser, S., Wellisch, D., Hornung, V., Jahrsdorfer, B., Giese, T., Endres, S., and Hartmann, G. (2004). Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help. Blood, 103, 3058–3064.
Poltorak, A., He, X., Smirnova, I., Liu, M.Y., Van Huffel, C., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., Freudenberg, M., Ricciardi-Castagnoli, P., Layton, B., and Beutler, B. (1998). Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science, 282, 2085–2088.
Robey, E. and Fowlkes, B.J. (1994). Selective events in T cell development. Annu. Rev. Immunol., 12, 675–705.
Ryan, K.R. and Evavold, B.D. (1998). Persistence of peptide-induced CD4+ T cell anergy in vitro. J. Exp. Med., 187, 89–96.
Sakaguchi, S. (2004). Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol., 22, 531–562.
Scott, R.S., McMahon, E.J., Pop, S.M., Reap, E.A., Caricchio, R., Cohen, P.L., Erp, H.S., and Matsushima, G.K. (2001). Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature, 411, 207–211.
Sebzda, E., Mariathasan, S., Ohteki, T., Jones, R., Bachmann, M.F., and Ohashi, P.S. (1999). Selection of the T cell repertoire. Annu. Rev. Immunol., 17, 829–874.
Shevach, E.M., McHugh, R.S., Piccirillo, C.A., and Thornton, A.M. (2001). Control of T-cell activation by CD4+CD25+ suppressor T cells. Immunol. Rev., 182, 58–67.
Shull, M.M., Ormsby, I., Kier, A.B., Pawlowski, S., Diebold, R.J., Yin, M., Alle, R., Sidman, C., Proetzel, G., Calvin, D., and et al. (1992). Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature, 359, 693–699.
Sloan-Lancaster, J., Evavold, B.D., and Allen, P.M. (1993). Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature, 363, 156–159.
Sloan-Lancaster, J., Evavold, B.D., and Allen, P.M. (1994). Th2 cell clonal anergy as a consequence of partial activation. J. Exp. Med., 180, 1195–1205.
Taylor, G.A., Carballo, E., Lee, D.M., Lai, W.S., Thompson, M.J., Patel, D.D., Schenkman, D.I., Gilkeson, G.S., Broxmeyer, H.E., Haynes, B.F., and Blackshear, P.J. (1996). A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity, 4, 445–454.
Tew, M.B., Johnson, R.W., Reveille, J.D., and Tan, F.K. (2001). A molecular analysis of the low serum deoxyribonuclease activity in lupus patients. Arthritis Rheum., 44, 2446–2447.
Tivol, E.A., Borriello, F., Schweitzer, A.N., Lynch, W.P., Bluestone, J.A., and Sharpe, A.H. (1995). Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity, 3, 541–547.
Tsao, B.P. (2000). Lupus susceptibility genes on human chromosome 1. Int. Rev. Immunol., 19, 319–334.
Vassilopoulos, D., Kovacs, B., and Tsokos, G.C. (1995). TCR/CD3 complex-mediated signal transduction pathway in T cells and T cell lines from patients with systemic lupus erythematosus. J. Immunol., 155, 2269–2281.
Wang, J., Zheng, L., Lobito, A., Chan, F.K., Dale, J., Sneller, M., Yao, X., Puck, J.M., Straus, S.E., and Lenardo, M.J. (1999). Inherited human caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell, 98, 47–58.
Yablonski, D. and Weiss, A. (2001). Mechanisms of signaling by the hematopoietic-specific adaptor proteins, SLP-76 and LAT and their B cell counterpart, BLNK/SLP-65. Adv. Immunol., 79, 93–128.
Yasutomo, K. (2003). Pathological lymphocyte activation by defective clearance of self-ligands in systemic lupus erythematosus. Rheumatology, 42, 214–222.
Yasutomo, K., Horiuchi, T., Kagami, S., Tsukamoto, H., Hashimura, C., Urushihara, M., and Kuroda, Y. (2001). Mutation of DNase1 in people with systemic lupus erythematosus. Nat. Genet., 28, 313–314.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Science+Business Media, Inc.
About this chapter
Cite this chapter
Yasutomo, K. (2005). Accumulation of Self-Antigens in Systemic Lupus Erythematosus. In: Zouali, M. (eds) Molecular Autoimmunity. Springer, Boston, MA. https://doi.org/10.1007/0-387-24534-0_20
Download citation
DOI: https://doi.org/10.1007/0-387-24534-0_20
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-24533-1
Online ISBN: 978-0-387-24534-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)